The following is an archived copy of a message sent to a Discussion List run by the Campaign Against Sanctions on Iraq.

Views expressed in this archived message are those of the author, not of the Campaign Against Sanctions on Iraq.

[Main archive index/search] [List information] [Campaign Against Sanctions on Iraq Homepage]

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

RE: Child Leukaemia Treatment in Iraq

Hi Mark,

The discussion of irregular arrivals of leukaemia drugs that I remember was
in the John Pilger / Felicity Arbuthnot documentary.  In that, Pilger
interviewed Prof. Karol Sikora, an oncologist in London.  Sikora stresses
the importance of carefully staged treatments, and the impossibility of
maintaining them in Iraq.  If you're interested in researching this further,
I would recommend speaking to Sikora.

The second people to speak to would be the people at the Office of the Iraq
Programme in New York.  In particular, Hasmik Egian is the information
officer, and it's her job to answer questions like this.  She can be phoned
in New York on +1 212 963 4341.

>From the point of view of imports, the most interesting question to me is
how many of the leukaemia drugs are NOT on the 'green lists' (Hasmik could
probably help with this).  Drugs that are on the green lists can be imported
without the Sanctions Committee's approval.  If the arrival of 'green list'
drugs is slow, it suggests that other factors are delaying them.  These
could include the supplier's reliability, which might be chosen for
political as well as commercial factors.

Proper treatment for leukaemia depends on much more, of course, than mere
availability of drugs.  Nurses and doctors must be capable of providing
treatment, and must be available.  This requires payment of their salaries,
and a budget for their training, both of which have been impeded by
sanctions.  Hospitals need to be well-equipped, clean and have electricity;
these too require a well-functioning system that sanctions have harmed.

I hope that this helps,

Colin Rowat

work | Room 406, Department of Economics | The University of Birmingham |
Birmingham, B15 2TT, UK | | (+44/0) 121 414 3754 |
(+44/0) 121 414 7377 (fax) |

personal | (+44/0) 7768 056 984 (mobile) | (+44/0) 7092 378 517 (fax) |
(707) 221 3672 (US fax) |

-----Original Message-----
[]On Behalf Of Mark
Sent: Thursday, February 21, 2002 9:25 AM
Subject: Child Leukaemia Treatment in Iraq

Dear All
I'm writing to you on a point of information I'm trying to clarify.  I'm
sure I read somewhere that the drugs used to treat leukaemia arrive in drips
and drabs because of the process of applying for a license.  I know that
they are needed all at once, but another key factor for me is the shelf-life
of the drugs: does anyone know if they have a limited shelf-life?
I've tried all kinds of searches on CASI's archive but have been unable to
source the specific reference.
Thanks for your help


Mark Sinjakli


Do You Yahoo!?
Get personalised at My Yahoo!.

Do You Yahoo!?
Get your free address at

This is a discussion list run by the Campaign Against Sanctions on Iraq
For removal from list, email
CASI's website - - includes an archive of all postings.

[Campaign Against Sanctions on Iraq Homepage]